Cyclic bis-benzimidazole ligands and metal complexes thereof

Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S472000, C540S476000, C546S273100

Reexamination Certificate

active

06376664

ABSTRACT:

BACKGROUND OF THE INVENTION
Naturally-occurring metallotetrapyrroles such as, for example, metalloporphyrins and other related metallotetrapyrroles (corrins, F430) are important cofactors in biology, where they serve as sensors,
1-5
transporters,
6,7
and catalysts.
8-14
Synthetic metallotetrapyrroles have also found numerous industrial applications, including the catalytic oxidation of organic substrates
15-19
and the fabrication of novel materials.
20-22
In light of their general importance and extensive applicability, it is desirable to have new compounds which are similar in structure and function to the tetrapyrrole ligands and metallotetrapyrroles, but which also have different structural features that are advantageous.
SUMMARY OF THE INVENTION
In accordance with the present invention, new compounds which are similar and function to tetrapyrrole ligands are provided. The new compounds are designated herein as “cyclic bis benzimidazole ligands”. One group of cyclic bis-benzimidazole (BBZ) ligands have the following formula:
R
1
and R
2
may be the same or different;
R
1
and R
2
are selected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, a benzyl group, a substituted 2-ethylphenyl group, a carbonyl group, a phenyl substituent, a tosyl group, and an alkylsulfonate group;
R
3
and R
4
may be the same or different;
R
3
and R
4
are selected from the group consisting of H, a methyl, and an ethyl;
R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, R
13
, R
14
, R
15
, R
16
, R
17
, and R
18
may be the same or different; and
R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, R
13
, R
14
, R
15
, R
16
, R
17
, and R
18
are selected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, fluoride, chloride, bromide, iodide, nitro, amino, a carboxylate, an ester, and a phenyl group.
Preferably, the BBZ ligand is an unsubstituted, a methyl substituted, or a benzyl substituted bis benzimidazole ligand.
The unsubstituted BBZ ligand is shown below:
Unsubstituted
The methyl substituted BBZ ligand is shown below:
The benzyl substituted BBZ ligand is shown below:
where
R
1′
, R
2″
, R
3′
, R
4′
, and R
5′
, are the same or different and
R
1′
R
2′
, R
3′
, R
4′
, and R
5′
, are elected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, fluoride, chloride, bromide, iodide, nitro, amino, a carboxylate, an ester, and a phenyl group.
Another group of the cyclic BBZ ligands, the reduced BBZ ligands, have the following formula
where
R
1
and R
2
may be the same or different;
R
1
and R
2
are selected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, a benzyl group, a substituted 2-ethylphenyl group, a carbonyl group, a phenyl substituent, a tosyl group, and an alkylsulfonate group;
R
3
and R
2
may be the same or different;
R
3
and R
4
are selected from the group consisting of H, a methyl, and an ethyl;
R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, R
13
, R
14
, R
15
, R
16
, R
17
, and R
18
may be the same or different;
R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, R
13
, R
14
, R
15
, R
16
, R
17
, and R
18
are selected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, fluoride, chloride, bromide, iodide, nitro, amino, a carboxylate, an ester, and a phenyl group;
R
19
and R
20
are the same or different: and
R
19
and R
20
are selected from the group consisting of H, an alkyl having 1 to 10 carbon atoms, and a benzyl derivative.
These bis-benzimidazoles, in a manner similar to phthalocyanines, are useful as non-linear optical materials for use in information processing, optical switching, optical frequency conversion and telecommunications. For example, various BBZ ligands and metal complexes are useful as optical switches in fiber-optic networks or other photonic devices. The bis-benzimidazole ligands may also serve as monomeric units in organic polymers that are used in electrochemical devices such as batteries, and amperometric sensors. The bis-benzimidazole ligands are also useful as monomeric units in the backbone of polymers which are used in optical devices such as optical sensors and optical data storage devices. Chiral bis-benzimidazole ligands are useful as an affinity ligand for chiral separations.
In the metal complexes made in accordance with the present invention, a metal ion is complexed to the two benzimidazole nitrogens as well as the two schiff base/or amine nitrogens of the BBZ ligand. Essentially any mono-, di- or trivalent metal can be used for this purpose. For example, Na, K, Ru, Cs, Ca, Mg, Ba, Sr, Fe, Co, Ni, Cu, Mn, Ga, Si, Ge, Sn and Sb can be used. Preferably the metal ion is a transition metal ion, more preferably iron or manganese. The bis-benzimidazole metal complexes are catalysts useful in many organic reactions such as, for example, the epoxidation of olefins, the polymerization of olefins, atom transfer reactions and hydrogenation reaction.
The present invention also relates to methods of making the bis-benzimidazole ligands and the metal complexes thereof. These methods involve cyclizing a 2-amino or 2-nitro phenyl-benzimidazole substituted at its 4 position with an acetal or aldehyde moiety by contact with an acid. If a metal ion is present during cyclization, the ligand will coordinate around the metal ion as it forms through cyclization. If a metal ion is not present, cyclization will nonetheless occur with the benzimidazole nitrogens becoming protonated. In either case, a stable cyclic bis-benzimidazole ligand will form.
Particular methods for preparing the bis-benzimidazole involve coupling an unsubstituted or substituted phenylenediamine precursor with a substituted phenylcarboxaldehyde, or an unsubstituted phenylcarboxaldehyde, or an aldehyde . Preferably, the coupling is achieved using copper acetates as a catalyst. One method comprises the following steps: (1) reducing the benzothiadiazole group of a phenylenediamine precursor to the deprotect the diamine, (2) coupling of the phenyl diamine with an aldehyde to form a benzimidazole group, preferably via copper catalysis (3) oxidizing the benzyl alcohol group to a carboxaldehyde (4) protecting the carboxaldehyde with ethylene glycol, (5) alkylating/substituting the benzimidazole nitrogen, (6) reducing the nitro group to the amine, and (7) deprotecting the aldehyde and cyclizing under acidic conditions to provide the BBZ ligand. The metal complex is formed by refluxing the desired metal with the BBZ ligand.
A second method for forming the BBZ ligand comprises the following steps (1) coupling of a phenyl diamine with an aldehyde to form a benzimidazole group, preferably via copper catalysis (2) alkylating/substituting the benzimidazole nitrogen, (3) dibrominating the methyl group on the phenyl ring, (4) converting the dibromide to a carboxaldehyde and (5) metal/acid catalyzed reducing the nitro group and cyclizing. A third method for forming the BBZ ligand comprises the following steps (1) coupling a phenyl diamine with an aldehyde to form a benzimidazole group, preferably via copper catalysis (2) alkylating/substituting the benzimidazole nitrogen, (3) oxidation of the aromatic methyl to a carboxaldehyde, and (4) metal/acid catalyzed reduction of the nitro group and cyclizing.
The present invention also relates to method of using a BBZ metal complex to prepare an epoxide. The method comprises contacting an olefin with an oxo transfer agent or oxidant and a BBZ metal complex in a mixture comprising an aqueous or organic substrate to provide an epoxide of the olefin.


REFERENCES:
patent: 3481945 (1969-12-01), Nichols et al.
patent: 5180821 (1993-01-01), Obermayer et al.
patent: 5674467 (1997-10-01), Maier et al.
patent: 5925744 (1999-06-01), Haner et al.
“Synthesis and Characterization of the Dimethyl-Substituted Bisbenzimidazole Ligand and Its Manganese Complex” by Kwok, et al.,Inorg. Chem., 2000, 39, 2367-2376.
“Structural Trends in First-Row Transition-Metal Bis(benzimikazole) Complexes” by Payra, et al.,Inorg.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic bis-benzimidazole ligands and metal complexes thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic bis-benzimidazole ligands and metal complexes thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic bis-benzimidazole ligands and metal complexes thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2836647

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.